Study reveals potential new strategy for managing inflammatory bowel disease
Celltrion unveils promising dose escalation results for subcutaneous infliximab
Related Posts
AI set to revolutionise pharmaceutical R&D says GlobalData
Survey finds AI to enhance productivity and cut costs in the next 12 months AI […]
Lab-grown lung cancer cells show potential to revolutionise treatment
The model could lead to more targeted treatments for the disease Cancer Research scientists have […]
Argenx presents new efgartigimod data at EULAR 2025
Rheumatology studies show promising results for Sjogren’s disease Argenx has presented positive phase 2 results […]